# Valbenazine for Tardive Dyskinesia Tied to Less Antipsychotic Drop-Off

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/meetingcoverage/neicongress/123792) · 2026-11-09 · Medicine
Page: https://themorning.science/story/valbenazine-for-tardive-dyskinesia-tied-to-less-antipsychotic-drop-off-afde870314148658
Kind: research · Impact: low

## In brief

- Starting valbenazine (Ingrezza) to treat tardive dyskinesia might reduce antipsychotic discontinuation in patients newly diagnosed with the side effect.
- The finding comes from a retrospective cohort study of Medicare claims, as reported by MedPage Today.

## Why it matters

Clinicians managing antipsychotic-treated patients with tardive dyskinesia may weigh this association when choosing treatment, though a retrospective claims study cannot establish cause and effect.

## Coverage

- [Valbenazine for Tardive Dyskinesia Tied to Less Antipsychotic Drop-Off](https://www.medpagetoday.com/meetingcoverage/neicongress/123792) — MedPageToday.com - medical news for physicians, 2026-11-09

Tags: tardive dyskinesia, valbenazine, antipsychotics, medicare, retrospective study

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science